Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat

Open access
Chen, Jian, Xie, Jun-Jun, Shi, Ke-Si, Gu, Yun-Tao, Wu, Cong-Cong, Xuan, Jun, Ren, Yue, Chen, Long, Wu, Yao-Sen, Zhang, Xiao-Lei, Xiao, Jian, Wang, De-Zhong, Wang, Xiang-Yang · 2018 · Cell Death & Disease

Abstract

Treatments for osteoarthritis (OA) are designed to restore chondrocyte function and inhibit cell apoptosis. Previous studies have shown that activation of the glucagon-like peptide-1 receptor (GLP-1R) leads to anti-inflammatory and anti-apoptotic effects. However, the role of GLP-1R in the pathological process of OA is unclear. In present work, we aimed to demonstrate the potential effect of GLP-1R on chondrocytes and elucidate its underlying mechanisms. We found that activation of GLP-1R with liraglutide could protect chondrocytes against endoplasmic reticulum stress and apoptosis induced by interleukin (IL)-1β or triglycerides (TGs). These effects were partially attenuated by GLP-1R small interfering RNA treatment. Moreover, inhibiting PI3K/Akt signaling abolished the protective effects of GLP-1R by increase the apoptosis activity and ER stress. Activating GLP-1R suppressed the nuclear factor kappa-B pathway, decreased the release of inflammatory mediators (IL-6, tumor necrosis factor α), and reduced matrix catabolism in TG-treated chondrocytes; these effects were abolished by GLP-1R knockdown. In the end, liraglutide attenuated rat cartilage degeneration in an OA model of knee joints in vivo. Our results indicate that GLP-1R is a therapeutic target for the treatment of OA, and that liraglutide could be a therapeutic candidate for this clinical application.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-017-0217-y

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 GLP-1R is mainly expressed in cartilage chondrocytes and decreases in degenerative cartilage. a, b Immunohistochemical staining of GLP-1R expression in normal and OA group (40×). c, d Representative western blots and quantification data of GLP-1R in normal and OA group. Columns represent mean ± SD, Significant differences between the normal and OA group are indicated as *P < 0.05, n = 5
Fig. 1 GLP-1R is mainly expressed in cartilage chondrocytes and decreases in degenerative cartilage. a, b Immunohistochemical staining of GLP-1R expression in normal and OA group (40×). c, d Representative western blots and quantification data of GLP-1R in normal and OA group. Columns represent mean ± SD, Significant differences between the normal and OA group are indicated as *P < 0.05, n = 5CC BY · PubMed Central
Fig. 2 Activation of GLP-1R by liraglutide decreases apoptosis in chondrocytes. a CCK-8 assays of chondrocytes treated with various concentrations of liraglutide for 24 h as shown above. b CCK-8 assays of liragltide-pretreated chondrocytes stimulated by IL-1β. c Chondrocytes were pretreated with liraglutide and then IL-1β and imaged by phase-contrast microscopy (20×). d–g Representative western blots and quantification data of Bax, Bcl-2 and cleaved-caspase 3 in each group. Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5
Fig. 2 Activation of GLP-1R by liraglutide decreases apoptosis in chondrocytes. a CCK-8 assays of chondrocytes treated with various concentrations of liraglutide for 24 h as shown above. b CCK-8 assays of liragltide-pretreated chondrocytes stimulated by IL-1β. c Chondrocytes were pretreated with liraglutide and then IL-1β and imaged by phase-contrast microscopy (20×). d–g Representative western blots and quantification data of Bax, Bcl-2 and cleaved-caspase 3 in each group. Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5CC BY · PubMed Central
Fig. 3 The anti-apoptotic effects of GLP-1R was modulated by PI3K/Akt signaling in chondrocytes. a, b Representative western blots and quantification data of p-Akt and Akt in each group. c, d TUNEL assay was used to assess the apoptosis of each group (scale bar: 50 μm). e, f Representative western blots and quantification data of p-Akt, Akt, Bax, Bcl-2, and cleaved-caspase 3 in each group. Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5
Fig. 3 The anti-apoptotic effects of GLP-1R was modulated by PI3K/Akt signaling in chondrocytes. a, b Representative western blots and quantification data of p-Akt and Akt in each group. c, d TUNEL assay was used to assess the apoptosis of each group (scale bar: 50 μm). e, f Representative western blots and quantification data of p-Akt, Akt, Bax, Bcl-2, and cleaved-caspase 3 in each group. Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5CC BY · PubMed Central
Fig. 4 Activation of GLP-1R inhibits ER stress via activation of PI3K/Akt signaling in chondrocytes. a–e Representative western blots and quantification data of GRP78, PDI, caspase12 and CHOP in each group. f–j Representative western blots and quantification data of GRP78, PDI, caspase12 and CHOP in each group. Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5
Fig. 4 Activation of GLP-1R inhibits ER stress via activation of PI3K/Akt signaling in chondrocytes. a–e Representative western blots and quantification data of GRP78, PDI, caspase12 and CHOP in each group. f–j Representative western blots and quantification data of GRP78, PDI, caspase12 and CHOP in each group. Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5CC BY · PubMed Central
Fig. 5 GLP-1R may relate ER stress and NF-κB pathway in chondrocytes. a–f Representative western blots and quantification data of p65, p-IκBα and IκBα, IL-6, TNF-α in each group. g Immunofluorescence staining of P65 proteins (green) and nucleus (blue) was labeled with DAPI (scale bar: 50 μm). Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5
Fig. 5 GLP-1R may relate ER stress and NF-κB pathway in chondrocytes. a–f Representative western blots and quantification data of p65, p-IκBα and IκBα, IL-6, TNF-α in each group. g Immunofluorescence staining of P65 proteins (green) and nucleus (blue) was labeled with DAPI (scale bar: 50 μm). Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5CC BY · PubMed Central
Fig. 6 GLP-1R activation decreased the ECM catabolic activity in TG-treated chondrocytes. a, b The relative mRNA expression of MMP-3 and collegan-II in each group. c, d Immunofluorescence staining of MMP-3 and collegan-II proteins in each group (scale bar: 50 μm). Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5
Fig. 6 GLP-1R activation decreased the ECM catabolic activity in TG-treated chondrocytes. a, b The relative mRNA expression of MMP-3 and collegan-II in each group. c, d Immunofluorescence staining of MMP-3 and collegan-II proteins in each group (scale bar: 50 μm). Columns represent mean ± SD, Significant differences between the treatment and control groups are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, n = 5CC BY · PubMed Central
Fig. 7 Liraglutide treatment ameliorated chondrocytes ER stress, associated apoptosis and cartilage degeneration in rat OA model. a HE staining in each group at 3 and 6 weeks (20×). b Safranin O staining in each group at 6 weeks (10×). c OARSI scores of each group at 6 weeks. d–g Immunohistochemical staining of cytoplasmic CHOP and cleaved-caspase3 expression in each group (40×)
Fig. 7 Liraglutide treatment ameliorated chondrocytes ER stress, associated apoptosis and cartilage degeneration in rat OA model. a HE staining in each group at 3 and 6 weeks (20×). b Safranin O staining in each group at 6 weeks (10×). c OARSI scores of each group at 6 weeks. d–g Immunohistochemical staining of cytoplasmic CHOP and cleaved-caspase3 expression in each group (40×)CC BY · PubMed Central
Fig. 8 A schematic diagram depicting the potential molecular mechanisms underlying GLP-1R mediated-chondroprotection against apoptosis and inflammation via regulating PI3K/Akt/ER stress and NF-κB signaling
Fig. 8 A schematic diagram depicting the potential molecular mechanisms underlying GLP-1R mediated-chondroprotection against apoptosis and inflammation via regulating PI3K/Akt/ER stress and NF-κB signalingCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 130

Metadata

Authors
Chen, J., Xie, J.-J., Shi, K.-S., Gu, Y.-T., Wu, C.-C., Xuan, J., Ren, Y., Chen, L., Wu, Y.-S., Zhang, X.-L., Xiao, J., Wang, D.-Z., & Wang, X.-Y.
Affiliations
Wenzhou Medical University (CN)
Venue
Cell Death & Disease
Published
2018-02-12
Volume
9
Issue
2
Pages
212-212
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2789512886
Cited by
130
References
66
Citations by year
2026: 22 · 2025: 37 · 2024: 11 · 2023: 9 · 2022: 21 · 2021: 5 · 2020: 13 · 2019: 9 · 2018: 3
FWCI
6.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Keywords
GLP-1 receptor, osteoarthritis, chondrocytes, endoplasmic reticulum stress, apoptosis, liraglutide, PI3K/Akt signaling, NF-κB signaling, IL-1β, triglycerides, cartilage degeneration, matrix catabolism, inflammation
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Inflammation, Osteoarthritis, Cytokines, Rats, Sprague-Dawley, Apoptosis, Chondrocytes, Rats, Endoplasmic Reticulum Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat. https://app.cochat.ai/papers/10.1038/s41419-017-0217-y
The paper
Chen, J., Xie, J.-J., Shi, K.-S., Gu, Y.-T., Wu, C.-C., Xuan, J., Ren, Y., Chen, L., Wu, Y.-S., Zhang, X.-L., Xiao, J., Wang, D.-Z., & Wang, X.-Y. (2018). Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat. Cell Death & Disease. https://doi.org/10.1038/s41419-017-0217-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.